Osimertinib

1 Drug classified under this active ingredient

Protein Kinase Inhibitor. Osimertinib 4 0mg, 80 mg.
F. C. TABS.: 30×40, 80mg. 80 mg×1/d until dis. progress. or unaccept. toxicity. If a dose is missed, the dose should be made up unless the next dose is due within 12 hrs. See lit.
Tmt. of adult pts. with local. advanc. or metast. epiderm. growth factor receptor (EGFR) T790M mutation-positive nonsmall- cell lung cancer (NSCLC, who have progress. on or after EGFR TKI ther.
C/I: Hypersens. Concom. use with st. john’s wort.